Saxenda in Edmonton: Daily GLP-1 Weight Management With Reliable Supply
Saxenda (liraglutide 3.0 mg) is the original GLP-1 receptor agonist approved by Health Canada for chronic weight management. While newer once-weekly options like Wegovy and Mounjaro often dominate headlines, Saxenda remains an evidence-based, reliably stocked daily injection for Edmonton-area patients — particularly those whose insurance plans cover it more readily than newer agents, who have not tolerated semaglutide, or who prefer a slower-titrating option. TelePlus Care offers same-day virtual consultations with CPSA-registered physicians who assess eligibility, review your bloodwork, and issue a prescription you can fill at any Edmonton pharmacy.
Book Your Appointment Now
Saxenda received Health Canada Notice of Compliance in February 2015 as the first GLP-1 approved specifically for chronic weight management. Pens cost CA$420-490 every four weeks in 2026 with stable supply. Eligibility: BMI 30+, or BMI 27+ with comorbidity. TelePlus Care provides virtual Edmonton-area consultations and prescriptions you fill at any local pharmacy.
- Health Canada approved Saxenda (liraglutide 3.0 mg) via Notice of Compliance in February 2015 for chronic weight management — the first GLP-1 with this indication in Canada.
- Saxenda costs CA$420-490 per 4-week supply (5 multi-dose pens) at Edmonton pharmacies in 2026 with reliable stock.
- Eligibility: BMI 30+ kg/m squared, or BMI 27+ with at least one weight-related comorbidity (hypertension, dyslipidemia, sleep apnea, Type 2 diabetes).
- Mechanism: daily GLP-1 receptor agonist; SCALE Obesity trial showed average 8.0% body weight loss at 56 weeks.
What Is Saxenda and How Does It Work?
Saxenda contains liraglutide 3.0 mg, a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk. It is administered as a once-daily subcutaneous injection using a multi-dose pen. Liraglutide mimics the natural gut hormone GLP-1, which slows gastric emptying, reduces appetite signaling in the brain, and prompts the pancreas to release insulin in response to meals. Although liraglutide has a shorter half-life than semaglutide (requiring daily rather than weekly dosing), it has a longer real-world track record — Saxenda has been Health Canada-approved for weight management since 2015, providing more than a decade of post-market safety data.
Who Qualifies for Saxenda in Edmonton?
Health Canada's approved indication is chronic weight management in conjunction with a reduced-calorie diet and increased physical activity. Most Edmonton physicians follow Obesity Canada's 2020 Clinical Practice Guidelines for eligibility.
- Adults with Body Mass Index of 30 kg/m squared or greater (Class I obesity or higher).
- Adults with BMI of 27 kg/m squared or greater plus at least one weight-related comorbidity — hypertension, dyslipidemia, Type 2 diabetes, or obstructive sleep apnea.
- Adolescents aged 12-17 with body weight above 60 kg and BMI in the 95th percentile (added indication in Canada).
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- No history of pancreatitis.
- Not currently pregnant or planning pregnancy.
The TelePlus Care Virtual Consultation Process
Edmonton patients complete the entire process virtually with CPSA-registered physicians. Each prescription is documented in your chart and shared with your family doctor on request.
- Step 1: Book online — most patients receive same-day or next-business-day availability.
- Step 2: Complete the intake form covering medical history, BMI, comorbidities, and goals.
- Step 3: Secure video consultation with your CPSA-registered physician (15-25 minutes) to confirm eligibility and discuss expectations.
- Step 4: Bloodwork review or fresh requisition to Alberta Precision Laboratories if labs are older than 12 months.
- Step 5: Prescription issued for any Edmonton-area pharmacy of your choice.
- Step 6: Structured follow-ups at 4, 12, and 24 weeks for dose titration, side-effect management, and progress review.
Required Bloodwork Before Starting Saxenda
Standard practice requires recent metabolic labs to establish baseline organ function. Alberta Precision Laboratories collection sites across Edmonton and the Capital Region make this convenient and AHCIP-covered.
- HbA1c — screens for prediabetes or undiagnosed Type 2 diabetes.
- Fasting plasma glucose.
- Lipid profile — total cholesterol, LDL, HDL, triglycerides.
- Kidney function — eGFR and serum creatinine.
- Liver enzymes — ALT and AST.
- TSH — thyroid screening with unexplained weight changes.
- Pregnancy test for women of reproductive age.
Cost of Saxenda in Edmonton (2026)
Saxenda is supplied as multi-dose pens — typically 5 pens per 4-week box at the 3.0 mg maintenance dose. Daily injection means cost is comparable to weekly options on a monthly basis.
- Saxenda titration weeks (0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg): CA$420-460 per 4-week supply.
- Saxenda 3.0 mg maintenance (4 weeks / 5 pens): CA$450-490.
- Annual cost without insurance at maintenance: approximately CA$5,400-6,400.
- TelePlus Care consultation: covered by AHCIP for Alberta residents; $80 for out-of-province virtual visits.
- AHCIP does not cover Saxenda. Private insurance plans (Sun Life, Manulife, Canada Life, Green Shield, Alberta Blue Cross employer plans) often cover Saxenda more readily than newer agents because of its longer post-market history. Confirm using DIN 02436533.
Side Effects of Saxenda
Saxenda's side-effect profile resembles other GLP-1s, though some patients find the daily dosing schedule allows for finer adjustment of dose timing relative to meals.
- Nausea — most common; typically peaks during titration and improves within 4-8 weeks.
- Diarrhea or constipation.
- Vomiting — most often during dose increases.
- Headache and fatigue.
- Hypoglycemia, especially in patients also taking insulin or sulfonylureas.
- Injection site reactions — minor redness or itching.
- Rare: pancreatitis — severe abdominal pain radiating to the back; seek urgent care.
- Rare: gallbladder problems including gallstones.
Saxenda Compared to Wegovy, Ozempic, and Mounjaro
Saxenda is the oldest GLP-1 approved for weight management in Canada. Newer molecules deliver greater average weight loss but carry trade-offs in cost, supply, and insurance access.
- Saxenda (liraglutide 3.0 mg, daily) — ~8.0% body weight loss at 56 weeks (SCALE Obesity). Reliable supply, decade of safety data.
- Wegovy (semaglutide 2.4 mg, weekly) — ~14.9% at 68 weeks (STEP-1). Better efficacy, but intermittent supply through 2026.
- Ozempic (semaglutide 2.0 mg, weekly) — ~12-15%, off-label for weight loss but reliable supply.
- Mounjaro (tirzepatide, weekly) — ~15-22% in SURMOUNT trials. Highest efficacy but newer and more expensive.
- Saxenda may be preferred when insurance covers it preferentially, when patients did not tolerate semaglutide, or when daily injection allows finer side-effect control.
Why Choose TelePlus Care for Saxenda in Edmonton
TelePlus Care provides Edmonton-area patients with timely, evidence-based access to GLP-1 weight management, including older and newer agents. Our physicians are registered with the College of Physicians and Surgeons of Alberta and follow Obesity Canada's clinical guidelines. We don't dispense medication — we issue prescriptions that you fill at any pharmacy in Edmonton, Sherwood Park, St. Albert, or the broader Capital Region. Same-day virtual visits, transparent pricing, AHCIP-covered lab requisitions, and structured follow-ups are standard. If your insurance covers Saxenda but not Wegovy or Mounjaro, our physicians can help you choose the option that fits your benefit plan.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Serving Communities Across Alberta
Edmonton, Sherwood Park, St. Albert, Leduc, Spruce Grove, Fort Saskatchewan, Beaumont, and surrounding Capital Region.
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call 911 or go to the nearest urgent care facility.
